Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kiminori Tomimatsu is active.

Publication


Featured researches published by Kiminori Tomimatsu.


Tetrahedron-asymmetry | 2003

Practical synthesis of (R)-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid: a key intermediate for a therapeutic drug for neurodegenerative diseases

Tatsuya Ito; Tomomi Ikemoto; Toru Yamano; Yukio Mizuno; Kiminori Tomimatsu

Abstract A practical method for the preparation of ( R )-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid ( R )- 2 , a key intermediate for a therapeutic drug for neurodegenerative diseases, has been developed. rac -Methyl 6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-(propionyloxy)phenyl) hexanoate rac - 9b was synthesized from 2-methylnaphthoquinone in seven steps. An optically active ester ( R )- 9b was readily obtained from the corresponding racemic ester by lipase-catalyzed resolution, followed by sulfation or phosphorylation. Sulfation by a sulfur trioxide pyridine complex or phosphorylation by phosphoryl chloride enabled facile isolation of the optically active ester simply by extraction. Optically active acid ( R )- 2 was synthesized in excellent enantiomeric excess by hydrolysis of ( R )- 9b followed by recrystallization. The present synthesis of ( R )- 2 was accomplished in 10 steps without requiring chromatographic purification.


Tetrahedron | 2002

Large-scale synthesis of new cyclazines, 5-thia-1,8b-diazaacenaphthylene-3-carboxylic acid derivatives having the peripheral 12π-electron ring system

Tomomi Ikemoto; Tetsuji Kawamoto; Hiroki Wada; Toru Ishida; Tatsuya Ito; Yasushi Isogami; Yoshiko Miyano; Yukio Mizuno; Kiminori Tomimatsu; Kazumasa Hamamura; Muneo Takatani; Mitsuhiro Wakimasu

Abstract The 5-thia-1,8b-diazaacenaphthylenes ( 2 and its ester, 8 ) are new cyclazines, in which a paramagnetic ring is present in the peripheral 12π-electron ring system. Three convenient methods of preparing 8 have been developed. One involved thioglycolation of a new compound, 5-fluoroimidazo[1,2- a ]pyridine ( 6b ), followed by the Duff reaction gave 8 in 64% yield without chromatographic purification.


Tetrahedron | 2000

A Practical Synthesis of the Chronic Renal Disease Agent, 4,5-Dihydro-3H-1,4,8b-triazaacenaphthylen-3-one Derivatives, Using Regioselective Chlorination of Ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxylate with N-Chlorosuccinimide

Tomomi Ikemoto; Tetsuji Kawamoto; Kiminori Tomimatsu; Muneo Takatani; Mitsuhiro Wakimasu

Abstract A convenient synthesis of the chronic renal disease agent, trifluoro-N-[4-(3-oxo-3,5-dihydro-4H-1,4,8b-triazaacenaphthylen-4-yl)butyl]methanesulfonamide (1a), for large scale has been developed via ethyl 5-(chloromethyl)imidazo[1,2-a]pyridine-3-carboxylate (3), which was given by the regioselective chlorination of ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxylate (6) with N-chlorosuccinimide (NCS) using AcOEt as a solvent in 83% yield. The condensation of 3 and primary amines gave 4,5-dihydro-3H-1,4,8b-triazaacenaphthylen-3-one derivatives (1) in good yields. The present synthesis of 1a was accomplished in five steps from 2-amino-6-methylpyridine (4) without requiring a chromatographic method.


Tetrahedron | 2001

Convenient efficient synthesis of TAK-779, a nonpeptide CCR5 antagonist: development of preparation of various ammonium salts using trialkylphosphite and N-halogenosuccinimide

Tomomi Ikemoto; Atsuko Nishiguchi; Hiroyuki Mitsudera; Mitsuhiro Wakimasu; Kiminori Tomimatsu

Abstract A convenient and efficient synthesis of TAK-779 (1a), a nonpeptide CCR5 antagonist, has been achieved. The new methylation of tertiary amine (2) using trimethyl phosphite and N-chlorosuccinimide, followed by the addition of HCl led to ammonium chloride (1a) in 89% isolated yield without requiring a chromatographic method. By this preparation, ammonium methanesulfonate (1e) could be obtained in 75% isolated yield.


Tetrahedron Letters | 2000

Efficient syntheses of a novel 5-thia-1-azacycl[3.3.2]azine ring system and 3H-1,4-diazacycl[3.3.2]azine derivatives

Tetsuji Kawamoto; Kiminori Tomimatsu; Tomomi Ikemoto; Hidenori Abe; Kazumasa Hamamura; Muneo Takatani

Novel 5-thia-1-azacycl[3.3.2]azine derivatives 1 , 5-thia-1,8b-diazaacenaphthylenes, have successfully been prepared. An X-ray crystallographic analysis of 1c revealed that the 5-thia-1-azacycl[3.3.2]azine ring system adopts a planar structure as to the internal ring nitrogen atom. The 1 H NMR spectrum for unsubstituted ring system 1d implies contribution of a paramagnetic ring current in the peripheral 12π-electron ring system. Also, 3 H -1,4-diazacycl[3.3.2]azine derivatives, 4-benzyl-4,5-dihydro-3 H -1,4,8b-triazaacenaphthylen(e)-3-ones 2 and -3,5-diones 3 were synthesized with high efficiency via 3-(trichloroacetyl)imidazo[1,2- a ]pyridine derivatives as new useful synthetic intermediates.


Tetrahedron Letters | 1983

Stable selenoxanthenium ylides : synthesis and new reductive cyclization of selenoxanthen-10-10(alkoxalyl alkoxycarbonyl)methanides and their related compounds

Tadashi Kataoka; Kiminori Tomimatsu; Hiroshi Shimizu; Mikio Hori

Abstract Stereoisomers of 9-substituted selenoxanthen-10-io (alkoxalyl alkoxycarbonyl)methanides were prepared from the corresponding selenoxides and activated acetylenes. In the reaction of 9-phenylselenoxanthene 10-oxide( 1c ) with methyl propiolate afforded an unexpected product, methyl 9-phenylselenoxanthen-9-ylpropiolate( 5 ) together with ylide( 2e ). The selenonium ylides underwent new reductive cyclization with sodium borohydride to afford new cyclic selenonium ylides.


Phosphorus Sulfur and Silicon and The Related Elements | 1983

CHEMISTRY OF CIS- AND TRANS-9-PHENYLSELENOXANTHENE-N-ARYLSULFONYLSELENILIMINES1

Kiminori Tomimatsu; Tadashi Kataoka; Hiroshi Shimizu; Mikio Hori

Abstract cis- and trans-9-Phenylselenoxanthene-N-(arylsulfonyl)selenilimines were synthesized and isolated. Their stereochemistry was ascertained from the NMR spectra. Cis isomers reacted with chloramine-T or -B by an SN 2 type substitution to form trans isomers, but the reverse reaction did not take place. When trans isomers were refluxed in toluene they underwent intermolecular 1,4 rearrangement to give 9-arylsulfonamido-9-phenylselenoxanthene. The cis isomers neither rearranged nor isomerized. On treatment with DABCO, both isomers rearranged intermolecularly to 9-(N-arylsulfonamido)selenoxanthenes at room temperature. Hydrolysis of both isomers yielded trans-9-phenylselenoxanthene 10-oxide. Reactions with p-methoxyphenylmagnesium bromide or methylmagnesium iodide afforded 9-(p-methoxyphenyl)-9-phenylselenoxanthene or 9-phenylselenoxanthene as a main product, respectively.


Tetrahedron Letters | 1982

Stereoisomers of selenilimines: isolation and reactions of 9-phenylselenoxanthene-N-arylsulfonylselenilimines

Mikio Hori; Tadashi Kataoka; Hiroshi Shimizu; Kiminori Tomimatsu

Abstract The isolates cis- and trans-9phenylselenoxanthene-N-arylsulfonylselenilimines were not interconverted thermally. cis-Isomers were converted to trans-isomers by chloramine-T or -B in a fashion of SN2 type substitution. cis-Isomers did not rearrange but trans-isomers rearranged thermally to 9-arylsulfonamido-9-phenylselenoxanthenes, whereas both isomers underwent the base-catalyzed intermolecular rearrangement.


Archive | 1992

Pyridine derivatives, their production and use

Muneo Takatani; Taketoshi Saijo; Kiminori Tomimatsu


Archive | 1991

Imidazopyridine derivatives and their use

Muneo Takatani; Yoshio Kozai; Kiminori Tomimatsu; Yumiko Shibouta

Collaboration


Dive into the Kiminori Tomimatsu's collaboration.

Top Co-Authors

Avatar

Tomomi Ikemoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tatsuya Ito

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mikio Hori

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tadashi Kataoka

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Atsuko Nishiguchi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Muneo Takatani

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hideo Hashimoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yumiko Shibouta

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tadao Kawarasaki

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge